Press Releases

PHASTAR, a global specialist biometrics contract research organization (CRO), has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost. PHASTAR Cares allows third-sector organisations to fulfil...

medmix Drug Delivery (Haselmeier) and AARDEX Group announced a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem. Clinical testing during new drug development is costly and time intensive for pharmaceutical and biotech companies....

BioAscent, the leading provider of integrated drug discovery services, has introduced a new web-based interface for customers using its compound management services. The Compound Connect interface provides BioAscent customers with a secure online inventory, ordering and tracking system for...

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and a leading manufacturer of injection, primary container, and infusion therapy devices, has announced it will expand its contract development and manufacturing services for parenteral drugs to global customers. Terumo is...

To help pharmaceutical brands deliver faster-to-market nasal spray solutions, Silgan Dispensing, a global leader in the design, development and distribution of highly engineered pumps and sprayers in the pharmaceutical, home and beauty markets, announces the launch of the Gemini™...

IFF's Pharma Solutions division—backed by 300 years of combined cellulosic excipient experience and housing leading brands like Avicel® and METHOCEL™, plus a robust seaweed-based excipient portfolio —will showcase its deep technical expertise, commitment to customers and investment in its...

Paradigm4’s REVEAL Integrative Analytics platform enables Alnylam Pharmaceuticals to discover novel, genetically-validated drug targets from population scale biobank genotype-phenotype datasets and underlies the extraordinary pace and productivity of Alnylam’s RNAi therapeutics pipeline. Using Paradigm4’s cloud-based scientific analytics platform and data...